Note 4 - Intangible Assets, Net

12 Months Ended

Jun. 30, 2014

Disclosure Text Block [Abstract]

Intangible Assets Disclosure [Text Block]

Note 4. Intangible Assets, net 

Intangible assets consist of trade names, license fees from the Branded Proprietary Products Segment, and unpatented technology from the Other Nutraceutical Businesses Segment. The carrying amount of other intangible assets, net is as follows as of:

	June 30, 2014						June 30, 2013
	Gross Carrying		Accumulated				Gross Carrying		Accumulated
	Amount		Amortization		Net		Amount		Amortization		Net
Trade names and patents	$	1,525	$	815	$	710	$	1,525	$	739	$	786
Unpatented technology		547		500		47		547		460		87
License agreement		347		224		123		347		203		144
Total	$	2,419	$	1,539	$	880	$	2,419	$	1,402	$	1,017

Amortization expense recorded on intangible assets for each of the fiscal years ended June 30, 2014 and 2013 was $137. Amortization expense is recorded on the straight-line method over periods ranging from 13 years to 20 years based on contractual or estimated lives and is included in selling and administrative expenses.  Tests for impairment or recoverability are performed at least annually and require significant management judgment and the use of estimates which the Company believes are reasonable and appropriate at the time of the impairment test.  Future unanticipated events affecting cash flows and changes in market conditions could affect such estimates and result in the need for an impairment charge.  The Company also re-evaluates the periods of amortization to determine whether circumstances warrant revised estimates of current useful lives.  No impairment losses were identified or recorded in the fiscal years ended June 30, 2014 and 2013 on the Company’s other intangible assets.

The estimated annual amortization expense for intangible assets for the five succeeding fiscal years is as follows:

Year ending	Amortization
June 30,	Expense
2015	$	137
2016		104
2017		97
2018		97
2019		97
Thereafter		348
Total	$	880